Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.
Mitera Biosciences has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Mitera Biosciences's investors include Cedars Sinai.
Mitera Biosciences is headquartered in Bellevue, United States.
Mitera Biosciences is a biotech innovator using non-invasive skin epigenetics to advance anti-aging insights.
Mitera Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mitera Biosciences — Funding & Investors." VCBacked, December 30, 2025, https://www.vcbacked.co/company/mitera-biosciences. Accessed August 14, 2026.
VCBacked. (2025). Mitera Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mitera-biosciences
{{cite web |title=Mitera Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/mitera-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated